VEGFA and cancer: Additional immunostaining for vascular endothelial growth factor (rabbit anti-VEGF, RB-9031-R7, Thermo Scientific, USA) showed that VEGF-positive cancer cells occupied the majority of the sites of both the primary tumor and the tumor emboli in the pulmonary arterioles (Fig. 4).